JB Chemicals & Pharmaceuticals Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹2851.95
- Today's High:
- ₹3037.7
- Open Price:
- ₹2865.3999
- 52W Low:
- ₹1802.8114
- 52W High:
- ₹2935
- Prev. Close:
- ₹2842.3501
- Volume:
- 14043
Company Statistics
- Market Cap.:
- ₹218.78 billion
- Book Value:
- 320.552
- Revenue TTM:
- ₹32.61 billion
- Operating Margin TTM:
- 19.81%
- Gross Profit TTM:
- ₹19.81 billion
- Profit Margin:
- 13.71%
- Return on Assets TTM:
- 12.01%
- Return on Equity TTM:
- 17.75%
Company Profile
JB Chemicals & Pharmaceuticals Limited had its IPO on under the ticker symbol JBCHEPHARM.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. JB Chemicals & Pharmaceuticals Limited has a staff strength of 5,095 employees.
Stock update
Shares of JB Chemicals & Pharmaceuticals Limited opened at ₹2865.4 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹2851.95 - ₹3037.7, and closed at ₹2926.8.
This is a +2.97% increase from the previous day's closing price.
A total volume of 14,043 shares were traded at the close of the day’s session.
In the last one week, shares of JB Chemicals & Pharmaceuticals Limited have increased by +5.21%.
JB Chemicals & Pharmaceuticals Limited's Key Ratios
JB Chemicals & Pharmaceuticals Limited has a market cap of ₹218.78 billion, indicating a price to book ratio of 6.8514 and a price to sales ratio of 5.6458.
In the last 12-months JB Chemicals & Pharmaceuticals Limited’s revenue was ₹32.61 billion with a gross profit of ₹19.81 billion and an EBITDA of ₹7.61 billion. The EBITDA ratio measures JB Chemicals & Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, JB Chemicals & Pharmaceuticals Limited’s operating margin was 19.81% while its return on assets stood at 12.01% with a return of equity of 17.75%.
In Q2, JB Chemicals & Pharmaceuticals Limited’s quarterly earnings growth was a positive 33.8% while revenue growth was a positive 14.2%.
JB Chemicals & Pharmaceuticals Limited’s PE and PEG Ratio
- Forward PE
- 26.1097
- Trailing PE
- 49.5057
- PEG
Its diluted EPS in the last 12-months stands at ₹57.05 per share while it has a forward price to earnings multiple of 26.1097 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into JB Chemicals & Pharmaceuticals Limited’s profitability.
JB Chemicals & Pharmaceuticals Limited stock is trading at a EV to sales ratio of 5.678 and a EV to EBITDA ratio of 25.8679. Its price to sales ratio in the trailing 12-months stood at 5.6458.
JB Chemicals & Pharmaceuticals Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 31.05%.
Balance sheet and cash flow metrics
- Total Assets
- ₹35.54 billion
- Total Liabilities
- ₹5.54 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 31.05%
JB Chemicals & Pharmaceuticals Limited ended 2024 with ₹35.54 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹35.54 billion while shareholder equity stood at ₹24.80 billion.
JB Chemicals & Pharmaceuticals Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹5.54 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹574.60 million in goodwill. Its cash balance stood at ₹769.30 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹3.83 billion.
JB Chemicals & Pharmaceuticals Limited’s total current assets stands at ₹15.28 billion while long-term investments were ₹0 and short-term investments were ₹2.16 billion. Its net receivables were ₹5.76 billion compared to accounts payable of ₹2.39 billion and inventory worth ₹4.30 billion.
In 2024, JB Chemicals & Pharmaceuticals Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, JB Chemicals & Pharmaceuticals Limited paid ₹0.31 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹2926.8
- 52-Week High
- ₹2935
- 52-Week Low
- ₹1802.8114
- Analyst Target Price
- ₹
JB Chemicals & Pharmaceuticals Limited stock is currently trading at ₹2926.8 per share. It touched a 52-week high of ₹2935 and a 52-week low of ₹2935. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹2610.63 and 200-day moving average was ₹2177.03 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5427.7% of the company’s stock are held by insiders while 2329.3% are held by institutions.
Frequently Asked Questions About JB Chemicals & Pharmaceuticals Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. The company provides its services in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.